摘要
背景:本研究旨在确定认知健康个体(CHI),轻度认知功能障碍(MCI)患者和轻度和中度痴呆患者的时空步态参数和/或其组合(S),无论病因如何的认知障碍。 方法:从洲际“步态,科学和衰退”(GOOD)计划中选择2099名参与者(1015名CHI,478名MCI患者,331名轻度痴呆患者和275名中度痴呆患者),合并不同的数据库横断面研究。平均值和变异系数(CoV)的时空步态参数记录在通常的步行与GAITRiteR系统。 结果:认知障碍的严重程度与所有步态参数的恶化有关。无论认知状态如何,步速都与认知功能障碍关系最为密切。步幅长度的高平均值和CoV表征中度痴呆,而步幅时间的CoV增加是MCI状态所特有的。 结论:本研究结果支持特定的认知障碍相关步态障碍的存在,认知功能障碍的不同阶段存在差异,可用于筛选认知障碍患者。
关键词: 流行病学,步态障碍,运动控制,认知障碍,步态评估,阿尔茨海默病。
Current Alzheimer Research
Title:Spatiotemporal Gait Characteristics Associated with Cognitive Impairment: A Multicenter Cross-Sectional Study, the Intercontinental “Gait, cOgnitiOn & Decline” Initiative
Volume: 15 Issue: 3
关键词: 流行病学,步态障碍,运动控制,认知障碍,步态评估,阿尔茨海默病。
摘要: Background: The study aims to determine the spatiotemporal gait parameters and/or their combination(s) that best differentiate between cognitively healthy individuals (CHI), patients with mild cognitive impairment (MCI) and those with mild and moderate dementia, regardless of the etiology of cognitive impairment.
Methods: A total of 2099 participants (1015 CHI, 478 patients with MCI, 331 patients with mild dementia and 275 with moderate dementia) were selected from the intercontinental “Gait, cOgnitiOn & Decline” (GOOD) initiative, which merged different databases from seven cross-sectional studies. Mean values and coefficients of variation (CoV) of spatiotemporal gait parameters were recorded during usual walking with the GAITRite® system.
Results: The severity of cognitive impairment was associated with worse performance on all gait parameters. Stride velocity had the strongest association with cognitive impairment, regardless of cognitive status. High mean value and CoV of stride length characterized moderate dementia, whereas increased CoV of stride time was specific to MCI status.
Conclusion: The findings support the existence of specific cognitive impairment-related gait disturbances with differences related to stages of cognitive impairment, which may be used to screen individuals with cognitive impairment.
Export Options
About this article
Cite this article as:
Spatiotemporal Gait Characteristics Associated with Cognitive Impairment: A Multicenter Cross-Sectional Study, the Intercontinental “Gait, cOgnitiOn & Decline” Initiative, Current Alzheimer Research 2018; 15 (3) . https://dx.doi.org/10.2174/1567205014666170725125621
DOI https://dx.doi.org/10.2174/1567205014666170725125621 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cholesterol, Copper and Aβ in Controls, MCI, AD and the AD Cholesterol- Lowering Treatment Trial (ADCLT)
Current Alzheimer Research A Longitudinal FDG-PET Study of Transgenic Mice Overexpressing GSK- 3β in the Brain
Current Alzheimer Research Inflammation in the CNS: Understanding Various Aspects of the Pathogenesis of Alzheimer's Disease
Current Alzheimer Research A More Accurate Approach to Molecular Genetics Analysis in Vascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Association between Periodontal Health Status and Cognitive Abilitie s. The Role of Cytokine Profile and Systemic Inflammation
Current Alzheimer Research The Role of Melatonin in Multiple Sclerosis, Huntington's Disease and Cerebral Ischemia
CNS & Neurological Disorders - Drug Targets Hepatocyte Growth Factor (HGF): Neurotrophic Functions and Therapeutic Implications for Neuronal Injury/Diseases
Current Signal Transduction Therapy RAGE Signaling in Cell Adhesion and Inflammation
Current Pediatric Reviews A Resurrection of 7-MEOTA: A Comparison with Tacrine
Current Alzheimer Research Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease
Current Neuropharmacology Etiology of Neuroinflammatory Pathologies in Neurodegenerative Diseases: A Treatise
Current Psychopharmacology Inducible Nitric Oxide Synthase as a Possible Target in Hypertension
Current Drug Targets Assessment of Persistent, Bioaccumulative and Toxic Organic Environmental Pollutants in Liver and Adipose Tissue of Alzheimer’s Disease Patients and Age-matched Controls
Current Alzheimer Research The Evolution of Schizophrenia: A Model for Selection by Infection, with a Focus on NAD
Current Pharmaceutical Design Syntheses and In-Vitro Evaluation of Novel Adamantane Based γ-Secretase Inhibitors
Current Medicinal Chemistry Aging Affects Nicotinic Acetylcholine Receptors in Brain
Central Nervous System Agents in Medicinal Chemistry A Role of the Parasympathetic Nervous System in Cognitive Training
Current Alzheimer Research The Blood-Brain Barrier: Its Influence in the Treatment of Brain Tumors Metastases
Current Cancer Drug Targets The Blood-Brain Barrier in NeuroAIDS
Current HIV Research Association of PICALM Gene Polymorphisms with Alzheimer's Disease: Evidence from an Updated Meta-Analysis
Current Alzheimer Research